Vertex Pharmaceuticals is pressing pause on a phase 1/2 cystic fibrosis (CF) trial over a tolerability issue, while reporting ...

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.

At the height of Texas summers, residents whose homes lack air conditioners have no escape from the extreme heat. And it's ...

Some Metro Detroit police agencies are signing on with ICE as a new program resurfaces in what police agencies have been allowed to do since the 1990s: ask about immigration status.

Heading into the report, Palantir's stock was already up 64.6% on the year and trading near its 52-week high. In addition, it was in a 200-day moving-average uptrend, and near overbought territory on ...

Q1 2025 Management View CEO William Feehery highlighted that Certara achieved $106 million in revenue for Q1 2025, ...

The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

A father was arrested after allegedly leaving two young children in a car so he could play skills games at a local tobacco ...

Fintel reports that on May 5, 2025, William Blair initiated coverage of Roper Technologies (NasdaqGS:ROP) with a Outperform ...

William Blair initiated coverage of Roper Technologies (ROP) with an Outperform rating. Roper is a diversified operator and acquirer of 29 independent, leading niche vertical software assets, the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The e-commerce giant is “pretty maniacally focused” on keeping prices low, CEO Andy Jassy told analysts Thursday.